MPT · Medical Properties Trust Inc
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1B | $972.02M | $995.55M | $871.8M | $1.54B | $1.54B | $1.25B | $854.2M | $784.52M | $704.75M | $541.14M | $441.88M | $312.53M | $242.52M | $198.13M | $132.32M | $108.02M | $114.04M | |
| — | $90.31M | $74.17M | $110.07M | $167.42M | $101.44M | $30.14M | $168.21M | $84.17M | — | — | — | — | — | — | — | — | — | |
| — | $881.72M | $921.38M | $761.73M | $1.38B | $1.44B | $1.22B | $685.99M | $700.35M | — | — | — | — | — | — | — | — | — | |
| — | 90.71% | 92.55% | 87.37% | 89.15% | 93.43% | 97.59% | 80.31% | 89.27% | — | — | — | — | — | — | — | — | — | |
| $7.43M | — | — | — | — | — | — | — | — | $5.81M | $2.71M | $3.79M | $1.85M | $2.45M | $1.48M | $724K | $4.38M | $3.8M | |
| $120.72M | $130.43M | $133.79M | $145.59M | $160.49M | $145.64M | $131.66M | $96.41M | $81M | $58.6M | $48.91M | $43.64M | $37.27M | $30.06M | $28.56M | $27.09M | $26.51M | $21.1M | |
| $280.73M | $272.82M | $453.75M | $616.13M | $345.58M | $333.78M | $275.95M | $156.58M | $141.49M | $131.98M | $97.6M | $71.83M | $55.16M | $38.82M | $35.59M | $35.48M | $26.31M | $26.31M | |
| — | — | $180M | — | — | — | — | — | $18M | $5.34M | $3.06M | $2.81M | $2.82M | $1.46M | $6.46M | $2.47M | $3.69M | $1.11M | |
| $958.48M | $942.61M | $1.03B | $1.2B | $898.2M | $873.38M | $749.53M | $510.55M | $446.6M | $396.12M | $351.87M | $178.64M | $169.58M | $88.99M | $68.27M | $62.15M | $65.81M | $46.49M | |
| — | — | — | — | — | — | — | — | — | $485.58M | $341.64M | $263.24M | $142.95M | $153.54M | $129.85M | $70.18M | $42.21M | $67.55M | |
| — | — | — | — | — | — | — | — | — | 68.9% | 63.13% | 59.57% | 45.74% | 63.31% | 65.54% | 53.03% | 39.08% | 59.24% | |
| — | — | — | — | — | — | — | — | — | $617.56M | $439.24M | $335.07M | $198.11M | $192.36M | $165.44M | $105.65M | $68.52M | $93.86M | |
| $527.89M | $510.36M | $417.82M | $411.17M | $359.04M | $367.39M | $328.73M | $237.83M | $223.27M | $176.95M | $159.6M | $120.88M | $98.16M | $66.75M | $58.24M | $43.81M | $33.98M | $37.65M | |
| $94K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $96K | $1.52M | $43K | |
| -$170.26M | -$266.73M | -$2.33B | -$356.88M | $315.07M | $59.6M | -$36.38M | $30.13M | $681.48M | -$14.71M | $29.84M | -$123.31M | -$92.15M | -$64.24M | -$56.98M | -$58.06M | -$39.18M | -$37.61M | |
| $99.6M | $97.85M | -$366.64M | $13.97M | $40.8M | $28.49M | $20.42M | $16.05M | $14.17M | $10.06M | — | — | — | — | — | — | — | — | |
| -$128.46M | -$237.32M | -$2.36B | -$686.77M | $959.72M | $730.89M | $463.33M | $373.78M | $1.02B | $293.92M | $219.11M | $141.43M | $51.14M | $90.03M | $72.89M | — | — | — | |
| -$3.64M | $38.62M | $44.1M | -$130.68M | $55.9M | $73.95M | $31.06M | -$2.62M | $927K | $2.68M | -$6.83M | $1.5M | $340K | $726K | $19K | $128K | $1.6M | $300K | |
| -$126.24M | -$277.05M | -$2.41B | -$556.48M | $902.6M | $656.02M | $431.45M | $374.68M | $1.02B | $289.79M | $225.05M | $139.6M | $50.52M | $96.99M | $89.9M | $26.54M | $22.91M | $36.33M | |
| — | -28.5% | -242.11% | -63.83% | 58.5% | 42.47% | 34.54% | 43.86% | 129.59% | 41.12% | 41.59% | 31.59% | 16.17% | 39.99% | 45.38% | 20.05% | 21.21% | 31.86% | |
| $1.13M | $1.11M | $1.98M | $384K | $1.22M | $919K | $822K | $1.72M | $1.79M | $1.45M | $889K | $329K | $274K | $224K | $177K | $178K | $99K | $37K | |
| $2.57M | -$14.56M | -$2.55B | -$454.79M | $880.14M | $670.62M | $443.03M | $369.98M | $984.53M | $356.65M | $205.03M | $88.63M | $37.55M | $100.53M | $89.65M | $17.95M | $19.27M | $36.37M | |
| USD/shares | — | -$0.46 | -$4.02 | -$0.93 | $1.50 | $1.11 | $0.81 | $0.87 | $2.77 | $0.82 | $0.86 | $0.64 | $0.29 | $0.64 | $0.67 | $0.23 | $0.22 | $0.45 |
| USD/shares | — | -$0.46 | -$4.02 | -$0.93G | $1.50G | $1.11 | $0.81 | $0.87 | $2.76 | $0.82 | $0.86 | $0.63 | $0.29 | $0.63 | $0.67 | $0.23 | $0.22 | $0.45 |
| shares | — | 600.89M | 600.25M | 598.52M | 598.63M | 588.82M | 529.24M | 427.08M | 365.36M | 349.9M | 260.41M | 218M | 170M | 151.44M | 132.33M | 110.62M | 100.71M | 78.12M |
| shares | — | 600.89M | 600.25M | 598.52M | 598.84M | 590.14M | 530.46M | 428.3M | 366.27M | 350.44M | 261.07M | 218.3M | 170.54M | 152.6M | 132.33M | 110.63M | 100.71M | 78.12M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $41.38M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
P/FFO uses the company-stated “Funds from operations per diluted share”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.